GlassScriptPhysician profile
Douglas K Andersen
NPI 1730599598
$6,606.93
in general payments reported to CMS, 2019-2025
48 companies · $1,715 in 2025
The $1,715 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,425 · 2020: $338 · 2021: $123 · 2022: $248 · 2023: $1,163 · 2024: $1,596 · 2025: $1,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,396 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,395.91 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $898.76 | 2019-2025 | Imfinzi, Lynparza, Tagrisso |
| Novartis Pharmaceuticals Corporation | $796.67 | 2019-2025 | |
| Pfizer INC. | $512.71 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $454.37 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $336.90 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| E.R. Squibb & Sons, L.L.C. | $263.65 | 2021-2025 | Opdivo, Opdualag |
| Amgen INC. | $248.15 | 2019-2021 | |
| Lilly USA, LLC | $244.01 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Daiichi Sankyo INC. | $211.24 | 2022-2025 | Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $206.69 | 2019-2025 | |
| Seagen INC. | $203.41 | 2019-2023 | Adcetris |
| Incyte Corporation | $195.35 | 2023-2025 | Jakafi, Monjuvi, Niktimvo |
| Genzyme Corporation | $172.58 | 2019-2025 | |
| Genentech USA, INC. | $172.20 | 2019-2024 | Tecentriq, Phesgo, Rituxan Hycela |
| Celgene Corporation | $147.37 | 2019-2025 | Reblozyl, Pomalyst |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Andersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.